仿制药生产商Viatris Inc.（VTRS）今日盘前股价大涨5.71%，引起市场广泛关注。这一显著涨幅主要源于公司发布的超预期第二季度财报。
根据公司公布的财报显示，Viatris第二季度每股收益达到62美分，远超分析师预期的56美分。季度营收也表现出色，达到35.8亿美元，高于市场预期的34.7亿美元。这些数据表明公司在本季度的经营状况优于市场预期，提振了投资者信心。
除了亮眼的季度业绩外，Viatris还重申了其2025年的业绩指引，预计全年收入将在135亿至140亿美元之间，每股收益维持在2.16美元到2.30美元区间。这一举措进一步增强了市场对公司未来发展前景的信心。值得注意的是，尽管今日股价大涨，但Viatris股票截至上一交易日仍累计下跌29.7%，显示出公司股价仍有较大的上涨空间。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.